Last reviewed · How we verify

NCT06983366

Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases

Recruiting now Last updated 18 July 2025
What this trial tests

trial testing Lung Ultrasound in COPD in 700 participants. Currently enrolling.

Timeline
30 May 2025
Primary endpoint
1 January 2026
1 March 2026

Quick facts

Lead sponsorAssiut University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment700
Start date30 May 2025
Primary completion1 January 2026
Estimated completion1 March 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

18 and older, any sex, with COPD or ILD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This upcoming case-control study aims to confirm the Lung Sliding Index (LSI), a new ultrasound score that measures how well the pleura moves, in various lung diseases. The study will check how well the LSI can tell apart different lung diseases (like pneumothorax, interstitial lung disease, COPD, pneumonia, and pulmonary edema), how it relates to signs of disease severity, and how consistent the results are between different operators who have received the same training. Secondary objectives include assessing patient and operator satisfaction and feasibility using validated Likert scales.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Lung Ultrasound

Trials testing the same drug.

Other recruiting trials for COPD

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06983366.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing